Patents by Inventor Lorenzo Piemonti

Lorenzo Piemonti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19
    Publication number: 20230141355
    Abstract: The present invention relates to CXCL8 inhibitors for use in the treatment of COVID-19 patients with pneumonia.
    Type: Application
    Filed: March 24, 2021
    Publication date: May 11, 2023
    Inventors: Marcello ALLEGRETTI, Flavio MANTELLI, Lorenzo PIEMONTI
  • INFLUENZA VIRUS AND TYPE 1 DIABETES
    Publication number: 20200087630
    Abstract: Type 1 diabetes mellitus is characterized by loss of pancreatic insulin-producing beta cells, resulting in insulin deficiency. The usual cause of this beta cell loss is autoimmune destruction. The inventors provide the first evidence of a causal link between influenza virus infection and the development of type 1 diabetes and/or pancreatitis. This causal link between infection and type 1 diabetes and/or pancreatitis provides various therapeutic, prophylactic and diagnostic opportunities.
    Type: Application
    Filed: July 25, 2019
    Publication date: March 19, 2020
    Applicants: Ospedale San Raffaele S.r.l., Istituto Zooprofilattico Sperimentale delle Venezie
    Inventors: Lorenzo Piemonti, Ilaria Capua
  • INFLUENZA VIRUS AND TYPE 1 DIABETES
    Publication number: 20180273912
    Abstract: Type 1 diabetes mellitus is characterized by loss of pancreatic insulin-producing beta cells, resulting in insulin deficiency. The usual cause of this beta cell loss is autoimmune destruction. The inventors provide the first evidence of a causal link between influenza virus infection and the development of type 1 diabetes and/or pancreatitis. This causal link between infection and type 1 diabetes and/or pancreatitis provides various therapeutic, prophylactic and diagnostic opportunities.
    Type: Application
    Filed: January 5, 2018
    Publication date: September 27, 2018
    Applicants: Ospedale San Raffaele S.r.l., Istituto Zooprofilattico Sperimentale delle Venezie
    Inventors: Lorenzo PIEMONTI, Ilaria CAPUA
  • Sulfonamides for the prevention of diabetes
    Patent number: 9556115
    Abstract: The use of sulfonamides of formula (I) wherein R and R1 are as defined in the description, for the preparation of medicaments for the prevention of diabetes, in particular of type-1 diabetes is herein disclosed.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: January 31, 2017
    Assignee: DOMPÉ FARMACEUTICI S.P.A.
    Inventors: Lorenzo Piemonti, Luisa Daffonchio, Marcello Allegretti
  • INFLUENZA VIRUS AND TYPE 1 DIABETES
    Publication number: 20150299667
    Abstract: Type 1 diabetes mellitus is characterized by loss of pancreatic insulin-producing beta cells, resulting in insulin deficiency. The usual cause of this beta cell loss is autoimmune destruction. The inventors provide the first evidence of a causal link between influenza virus infection and the development of type 1 diabetes and/or pancreatitis. This causal link between infection and type 1 diabetes and/or pancreatitis provides various therapeutic, prophylactic and diagnostic opportunities.
    Type: Application
    Filed: October 10, 2013
    Publication date: October 22, 2015
    Applicants: OSPEDALE SAN RAFFAELE S.R.L., ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE
    Inventors: Lorenzo PIEMONTI, Ilaria CAPUA
  • SULFONAMIDES FOR THE PREVENTION OF DIABETES
    Publication number: 20150011639
    Abstract: The use of sulfonamides of formula (I) wherein R and R1 are as defined in the description, for the preparation of medicaments for the prevention of diabetes, in particular of type-1 diabetes is herein disclosed.
    Type: Application
    Filed: September 26, 2014
    Publication date: January 8, 2015
    Inventors: Lorenzo PIEMONTI, Luisa DAFFONCHIO, Marcello ALLEGRETTI
  • Sulfonamides for the prevention of diabetes
    Patent number: 8846755
    Abstract: The use of sulfonamides of formula (I) wherein R and R1 are as defined in the description, for the preparation of medicaments for the prevention of diabetes, in particular of type-1 diabetes is herein disclosed.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: September 30, 2014
    Assignee: Dompé S.p.A.
    Inventors: Lorenzo Piemonti, Luisa Daffonchio, Marcello Allegretti
  • SULFONAMIDES FOR THE PREVENTION OF DIABETES
    Publication number: 20130059908
    Abstract: The use of sulfonamides of formula (I) wherein R and R1 are as defined in the description, for the preparation of medicaments for the prevention of diabetes, in particular of type-1 diabetes is herein disclosed.
    Type: Application
    Filed: October 6, 2010
    Publication date: March 7, 2013
    Applicant: DOMPE' S.P.A.
    Inventors: Lorenzo Piemonti, Luisa Daffonchio, Marcello Allegretti
  • INHIBITORS OF CXCR1/2 AS ADJUVANTS IN THE TRANSPLANT OF PANCREATIC ISLETS
    Publication number: 20120202884
    Abstract: The invention relates to CXCR1 and/or CXCR2 inhibitors for the preparation of a medicament for use as an adjuvant in the transplant of pancreatic islets in Type 1 diabetes patients. In particular, the compounds that can be used according to the invention have the following formula (I) in which R and R? are as defined in the description.
    Type: Application
    Filed: October 6, 2010
    Publication date: August 9, 2012
    Applicant: DOMPE' S.P.A.
    Inventors: Lorenzo Piemonti, Luisa Daffonchio, Marcello Allegretti